Public Employees Retirement System of Ohio Has $5.19 Million Stock Position in Solventum Co. (NYSE:SOLV)

Public Employees Retirement System of Ohio reduced its stake in shares of Solventum Co. (NYSE:SOLV - Free Report) by 16.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 74,425 shares of the company's stock after selling 14,356 shares during the quarter. Public Employees Retirement System of Ohio's holdings in Solventum were worth $5,189,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of SOLV. MML Investors Services LLC raised its holdings in shares of Solventum by 3.2% during the 3rd quarter. MML Investors Services LLC now owns 5,345 shares of the company's stock worth $373,000 after buying an additional 168 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its holdings in shares of Solventum by 4.2% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,966 shares of the company's stock worth $346,000 after acquiring an additional 200 shares during the last quarter. National Bank of Canada FI boosted its stake in shares of Solventum by 4.0% in the 2nd quarter. National Bank of Canada FI now owns 6,093 shares of the company's stock valued at $314,000 after purchasing an additional 236 shares in the last quarter. IVC Wealth Advisors LLC increased its position in Solventum by 5.0% during the 3rd quarter. IVC Wealth Advisors LLC now owns 6,649 shares of the company's stock worth $464,000 after purchasing an additional 318 shares in the last quarter. Finally, KKM Financial LLC lifted its stake in Solventum by 7.9% in the 3rd quarter. KKM Financial LLC now owns 4,367 shares of the company's stock valued at $304,000 after purchasing an additional 319 shares during the last quarter.

Analysts Set New Price Targets

SOLV has been the topic of a number of research reports. Mizuho assumed coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a "neutral" rating and a $70.00 target price on the stock. BTIG Research began coverage on Solventum in a research report on Thursday, September 5th. They issued a "neutral" rating for the company. Morgan Stanley boosted their price target on Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a report on Monday, November 11th. Stifel Nicolaus initiated coverage on shares of Solventum in a report on Tuesday, October 8th. They issued a "buy" rating and a $82.00 price objective for the company. Finally, Piper Sandler boosted their target price on shares of Solventum from $71.00 to $75.00 and gave the stock a "neutral" rating in a report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Solventum currently has an average rating of "Hold" and an average price target of $68.29.

Solventum Stock Down 0.6 %

SOLV stock traded down $0.45 during trading on Friday, hitting $69.56. The company had a trading volume of 637,853 shares, compared to its average volume of 824,329. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. Solventum Co. has a one year low of $47.16 and a one year high of $96.05. The business has a 50-day moving average of $70.91 and a 200-day moving average of $63.24.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.